Financial Ratios CytomX Therapeutics, Inc.

Revenues

Selling General & Admin Expenses, Total

R&D Expenses

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

Restructuring Charges

Income Tax Expense

Net Income to Company

Preferred Dividend and Other Adjustments

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

EBITDA

EBITA

EBIT

EBITDAR

Total Revenues (As Reported)

Effective Tax Rate - (Ratio)

Current Domestic Taxes

Total Current Taxes

Deferred Domestic Taxes

Total Deferred Taxes

Normalized Net Income

Interest on Long-Term Debt

General and Administrative Expenses

Research And Development Expense From Footnotes

Net Rental Expense, Total

Stock-Based Comp., R&D Exp. (Total)

Stock-Based Comp., G&A Exp. (Total)

Stock-Based Comp., Other (Total)

Total Stock-Based Compensation

Cash And Equivalents

Short Term Investments

Accounts Receivable, Total

Prepaid Expenses

Gross Property Plant And Equipment

Accumulated Depreciation

Goodwill

Other Intangibles, Total

Other Long-Term Assets, Total

Accounts Payable, Total

Accrued Expenses, Total

Current Portion of Leases

Current Income Taxes Payable

Unearned Revenue Current, Total

Other Current Liabilities

Long-Term Leases

Unearned Revenue Non Current

Deferred Tax Liability Non Current

Other Non Current Liabilities

Common Stock, Total

Additional Paid In Capital

Retained Earnings

Comprehensive Income and Other

Total Common Equity

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent Oper. Leases

Account Code - Inventory Valuation

Machinery, Total

Full Time Employees

Part Time Employees

Net Income

Depreciation & Amortization - CF

Amortization of Goodwill and Intangible Assets - (CF)

Depreciation & Amortization, Total

(Gain) Loss From Sale Of Asset

(Gain) Loss on Sale of Investments - (CF)

Asset Writedown & Restructuring Costs

Stock-Based Compensation (CF)

Other Operating Activities, Total

Change In Accounts Receivable

Change In Accounts Payable

Change in Unearned Revenues

Change in Other Net Operating Assets

Capital Expenditure

Sale of Property, Plant, and Equipment

Investment in Marketable and Equity Securities, Total

Long-Term Debt Issued, Total

Total Debt Issued

Issuance of Common Stock

Other Financing Activities, Total

Cash Income Tax Paid (Refund)

Change In Net Working Capital

Net Debt Issued / Repaid